EDP Sciences logo
Search
Menu
All issues Volume 42 / No 1 (January-February 2002) Reprod. Nutr. Dev., 42 1 (2002) 55-64 References
Free Access
Issue
Reprod. Nutr. Dev.
Volume 42, Number 1, January-February 2002
Page(s) 55 - 64
DOI https://doi.org/10.1051/rnd:2002006

References

  1. Adlercreutz H., Bannwart C., Wahala K., Makela T., Brunow G., Hase T., Arosemena P.J., Kellis J.T., Vickery L.E., Inhibition of humanaromatase by mammalian lignans and isoflavonoid phytoestrogens, J. Steroid Biochem. Mol. Biol. 44 (1993) 147-153.
  2. Adlercreutz H., Markkanen H., Watanabe S., Plasma concentrations of phyto-oestrogens in Japanese men, Lancet 13 (1993) 1209-1210.
  3. Adlercreutz H., Goldin B.R., Gorbach S.L., Hockerstedt K.A.V., Watanabe S., Hamalainen E.K., Markkanen M.H., Makela T.H., Wahala K.T., Soybean phytoestrogen intake and cancer risk, J. Nutr. 125 (1995) 757s-770s.
  4. Agarwal M.L., Agarwal A., Taylor W.R., Chernova O., Sharma Y., Stark G.A., A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides, Proc. Natl. Acad. Sci. USA 95 (1998) 14775-14780.
  5. Bradbury R.B., White D.E., Oestrogens and related substances in plants, Vitam. Horm. 12 (1954) 207-233.
  6. Eldridge A., Kwolek W.F., Soybean isoflavones: effect of environment and variety on composition, J. Agric. Food Chem. 31 (1983) 394-396.
  7. Frey R., Singletary K., Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells; involvement of Cdc2, p21(waf/cip1), p27, and Cdc25C expression, Biochem. Pharmacol. 61 (2001) 979-989.
  8. Fried J., Perez A.G., Clarkson B.D., Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures. Some pitfalls in staining and data analysis, J. Histochem. Cytochem. 26 (1978) 921.
  9. Fu L., Minden M.D., Benchimol S., Translational regulation of human p53 gene expression, EMBO J. 15 (1996) 4392-4401.
  10. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C., Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res. 54 (1994) 4855-4878.
  11. Greene L.A., Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 phenochromocytoma cells in serum-free medium, J. Cell Biol. 78 (1978) 747-755.
  12. Hsu J., Hung H., Chen C., Hsu W., Ying C., Effects of the Dietary Phytoestrogen Biochanin A on Cell Growth in the Mammary Carcinoma Cell Line MCF-7, J. Nutr. Biochem. 10 (1999) 510-517.
  13. Hsu J., Jean T., Chan M., Ying C., Differential Display Screening for Specific Gene Expression Induced by Dietary Nonsteroidal Estrogen, Mol. Reprod. Dev. 52 (1999) 141-148.
  14. Hsu J., Hsu W.L., Ying C., Dietary phytoestrogen regulates estrogen receptor gene expression in human mammary carcinoma cells, Nutr. Res. 19 (1999) 1447-1457.
  15. Hupp T.R., Sparks A., Lane D.P., Small peptides activate the latent sequence-specific DNA binding function of p53, Cell 83 (1995) 237-245.
  16. Iwamoto H., Sakai H., Tada S., Nakamuta M., Nawata H., Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion, J. Lab. Clin. Med. 134 (1999) 83-89.
  17. Kuerbitz S.J., Plunkett B.S., Walsh W.V., Kastan M.B., Wild-type p53 is a cell cycle checkpoint determinant following irradiation, Proc. Natl. Acad. Sci. USA 89 (1992) 7491-7495.
  18. Lee A.W., Nambirajan S., Moffat J.G., CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells, Oncogene 18 (1999) 7477-7494.
  19. Markaverich B.M., Roberts R.R., Alejandro M.A., Johnson G.A., Middleditch B.S., Clark J.H., Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition, J. Steroid Biochem. Mol. Biol. 30 (1988) 71-78.
  20. Martin P.M., Horwitz K.B., Messina M.J., Persky V., Setchell K.D.R., Barnes S., Soy intake and cancer risk: A review of the in vitro and in vivo data, Nutr. Cancer 21 (1994) 113-131.
  21. Miksicek R., Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor, J. Steroid Biochem. Mol. Biol. 49 (1994) 153-160.
  22. Morris S.M., Chen J.J., Domon O.E., Mcgarrity L.J., Bishop M.E., Manjanatha M.G., Casciano D.A., p53, mutations and apoptosis in genistein-exposed human lymphoblastoid cells, Mutat. Res. 405 (1998) 41-56.
  23. Morton M.S., Wilcox G., Wahlqvist M.L., Griffiths K., Determination of lignans and isoflavonoids in human female plasma following dietary supplementation, J. Endocrinol. 142 (1994) 51-259.
  24. Peterson G., Evaluation of the biochemical targets of genistein in tumor cells, J. Nutr. 125 (1995) 784s-770s.
  25. Peterson G., Barnes S., Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene, Biochem. Biophys. Res. Commun. 179 (1991) 661-667.
  26. Pike M.C., Spicer D.C., Dahmoush L., Press M.F., Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk, Epidemiol. Rev. 15 (1993) 17-35.
  27. Prall O.W., Rogan E.M., Musgrove E.A., Watts C.K., Sutherland R.L., c-myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry, Mol. Cell Biol. 18 (1998) 4499-4508.
  28. Prall O.W., Rogan E.M., Sutherland R.L., Estrogen regulation of cell cycle progression in breast cancer cells, J. Steroid Biochem. Mol. Biol. 65 (1998) 169-174.
  29. Rudkin B.B., Lazarovici P., Levi B., Abe Y., Fujita K., Guroff G., Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation, EMBO J. 8 (1989) 3319-3325.
  30. Sathyamoorthy N., Wang T.T.Y., Phang J.M., Stimulation of pS2 expression by diet-derived compounds, Cancer Res. 79 (1994) 957-961.
  31. Schmidt E.V., The role of c-myc in cellular growth control, Oncogene 13 (1999) 2988-2996.
  32. Schwartz D., Almog N., Peled A., Goldfinger N., Rotter V., Role of wild type p53 in the G sub(2) phase: Regulation of the gamma-irradiation induced delay and DNA repair, Oncogene 15 (1997) 2597-2607.
  33. Spinozzi F., Pagliacci M.C., Migliorati G., Moraca R., Grignani F., Riccardi C., Nicoletti I., The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells, Leukemia Res. 18 (1994) 431-439.
  34. Steinmetz K., Potter J.D., in: Vegetables, fruit, and cancer. II. Mechanisms, Cancer Causes Control 2 (1991) 427-442.
  35. Thompson A.M., Steel C.M., Chetty U., Hawkins R.A., Miller W.R., Carter D.C., Forrest A.P., Evans H.J., p53 gene mRNA expression and chromosome 17p allele loss in breast cancer, Br. J. Cancer 61 (1990) 74-78.
  36. Wang C., Kurzer M.S., Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells, Nutr. Cancer 28 (1997) 236-247.
  37. Wang C., Kurzer M.S., Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors, Nutr. Cancer 31 (1998) 90-100.
  38. Wang T.T.Y., Sathyamoorthy N., Phang J.M., Molecular effect of genistein on estrogen receptor mediated pathways, Carcinogenesis 17 (1996) 271-275.
  39. Whitten P.L., Russell E., Naftolin F., Influence of phytoestrogen diets on estradiol action in the rat uterus, Steroids 59 (1994) 443-449.
  40. Wu R.C., Schonthal A.H., Activation of p53-pathway in response to disruption of cell-matrix interactions, J. Biol. Chem. 14 (1997) 29091-29098.
  41. Ying C., Lin D-H., Sarkar D.H., Chen T-T., Interaction between Estrogen Receptor and Pit-1 Protein is Influenced by Estrogen in Pituitary Cells, J. Steroid Biochem. Mol. Biol. 68 (1999) 145-152.
  42. Ziegler R.G., Hoover R.N., Pike M.C, Hildesheim A., Nomura A.M., West D.W., Wu A.H., Pike M.C., Lake A.J., Horn-Ross P.L., Kolonel L.N., Siiteri P.K., Fraumeni J.F. Jr., Migration patterns and breast cancer risk in Asian-American women, J. Natl. Cancer Inst. 85 (1993) 1819-1827.
Abstract

Copyright INRA, EDP Sciences